CDKN2A and chronic obstructive pulmonary disease: Variations in p16INK4a expression were significantly different between the two groups (p = 0.050; Figure 4B), with enhanced expression in healthy myotubes (+17.7%) and decreased expression in COPD myotubes (−2.4%).